This study aims to investigate the effects of Prolyl 4‐hydroxylase subunit alpha‐1 (P4HA1) inhibition on CRC tumor growth, metastasis, and tumor‐associated macrophage (TAM) infiltration. The gene discussed is P4HA1; the disease is neoplasm.